Axa’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,200
| Closed | -$216K | – | 1246 |
|
|
2022
Q1 | $216K | Sell |
13,200
-5,900
| -31% | -$96.5K | ﹤0.01% | 1144 |
|
|
2021
Q4 | $312K | Sell |
19,100
-4,400
| -19% | -$71.9K | ﹤0.01% | 1081 |
|
|
2021
Q3 | $300K | Buy |
+23,500
| New | +$300K | ﹤0.01% | 1143 |
|
|
2020
Q3 | – | Sell |
-16,980
| Closed | -$196K | – | 1372 |
|
|
2020
Q2 | $196K | Sell |
16,980
-21,711
| -56% | -$251K | ﹤0.01% | 1182 |
|
|
2020
Q1 | $530K | Sell |
38,691
-10,300
| -21% | -$141K | ﹤0.01% | 959 |
|
|
2019
Q4 | $289K | Hold |
48,991
| – | – | ﹤0.01% | 1080 |
|
|
2019
Q3 | $260K | Sell |
48,991
-1,980
| -4% | -$10.5K | ﹤0.01% | 1211 |
|
|
2019
Q2 | $392K | Sell |
50,971
-7,977
| -14% | -$61.3K | ﹤0.01% | 1114 |
|
|
2019
Q1 | $1.17M | Buy |
58,948
+31,817
| +117% | +$633K | ﹤0.01% | 944 |
|
|
2018
Q4 | $358K | Buy |
27,131
+18,580
| +217% | +$245K | ﹤0.01% | 1145 |
|
|
2018
Q3 | $314K | Buy |
8,551
+3,951
| +86% | +$145K | ﹤0.01% | 1221 |
|
|
2018
Q2 | $161K | Buy |
+4,600
| New | +$161K | ﹤0.01% | 1317 |
|